Literature DB >> 16426485

Complex dynamics and stability of resistance to antimalarial drugs.

I M Hastings1.   

Abstract

A succession of antimalarial drugs has been deployed to treat human falciparum malaria but each has, in turn, been nullified by the spread of drug resistance. The consensus view has always been that, once present, resistance will inevitably rapidly increase to 100%. However, recent field evidence has shown this is not inevitable, and that drug resistance may initially spread and then stabilize at relatively low frequencies. It is proposed that intense competition between separate malaria clones co-infecting the same human can generate complex dynamics capable of explaining this observation. Standard population genetic analysis confirms this assertion. The dynamics underlying the evolution of antimalarial resistance may therefore be much more complex than previously realized, and can resolve the apparent paradox between field data and the underlying theory of the evolution of resistance. This explanation is novel and the results are equally applicable to other parasitic species where multiple infections of the same host are common.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426485     DOI: 10.1017/S0031182005009790

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  36 in total

1.  Superinfection and the evolution of resistance to antimalarial drugs.

Authors:  Eili Y Klein; David L Smith; Ramanan Laxminarayan; Simon Levin
Journal:  Proc Biol Sci       Date:  2012-07-11       Impact factor: 5.349

2.  Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.

Authors:  Silvie Huijben; William A Nelson; Andrew R Wargo; Derek G Sim; Damien R Drew; Andrew F Read
Journal:  Evolution       Date:  2010-08-19       Impact factor: 3.694

3.  Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.

Authors:  K Stepniewska; N J White
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

4.  Benefits of using multiple first-line therapies against malaria.

Authors:  Maciej F Boni; David L Smith; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-09       Impact factor: 11.205

5.  The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.

Authors:  S Huijben; D G Sim; W A Nelson; A F Read
Journal:  J Evol Biol       Date:  2011-08-23       Impact factor: 2.411

6.  The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy.

Authors:  Andrew F Read; Troy Day; Silvie Huijben
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

7.  Approximations for the hitchhiking effect caused by the evolution of antimalarial-drug resistance.

Authors:  Kristan A Schneider; Yuseob Kim
Journal:  J Math Biol       Date:  2010-07-11       Impact factor: 2.259

8.  Population genetic structure of Plasmodium falciparum in the two main African vectors, Anopheles gambiae and Anopheles funestus.

Authors:  Zeinab Annan; Patrick Durand; Francisco J Ayala; Céline Arnathau; Parfait Awono-Ambene; Frédéric Simard; Fabien G Razakandrainibe; Jacob C Koella; Didier Fontenille; François Renaud
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

9.  Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.

Authors:  Allen L Malisa; Richard J Pearce; Salim Abdulla; Hassan Mshinda; Patrick S Kachur; Peter Bloland; Cally Roper
Journal:  Malar J       Date:  2010-07-05       Impact factor: 2.979

10.  Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.

Authors:  Conner I Sandefur; Jason M Wooden; Isaac K Quaye; Worachart Sirawaraporn; Carol Hopkins Sibley
Journal:  Mol Biochem Parasitol       Date:  2007-03-20       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.